In the present study, RSK1, but not RSK2, was decreased by inhibition of FLT3-ITD in MV4-11 and primary AML cells, while inhibition of PIM did not show any effect on expression level of RSK1 or RSK2 in these cells (Figure 3G). This evidence concerns the gene FLT3 and acute myeloid leukemia.